The Iodine-123 Meitner-Auger PARP1 inhibitor (123I-MAPi), an iodine-123 labeled PARP1 inhibitor, is a targeted therapy for GBM that utilizes Auger electrons for precise apoptosis induction 118. The gene discussed is PARP1; the disease is glioblastoma.